This medically approved, FDA-licensed technology helps people recover knotted muscles, upset nerves, and more
O-GlcNAcylation: a novel therapeutic target for brain disorders As discussed above, O-GlcNAcylation is implicated in various CNS disorders, including neurodevelopmental disorders, neurodegenerative diseases, psychiatric diseases, and CNS injuries
Consequently, these epigenetic shifts observed in monocytes could serve as a novel target for gout therapeutics (24) ( Figure 1 )
There are many ways these compounds can be used to study metabolic regulation, so researchers can explore multiple aspects of cellular metabolism
Prevalence of attention-deficit/hyperactivity disorder in individuals with autism spectrum disorder: A meta-analysis